ALLIANCEBERNSTEIN L.P. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$342,507
-43.4%
161,560
+27.1%
0.00%
Q2 2023$605,139
+4.3%
127,130
+24.9%
0.00%
Q1 2023$580,260
-80.9%
101,800
-66.3%
0.00%
-100.0%
Q4 2022$3,045,162
+33.5%
301,800
+196.5%
0.00%0.0%
Q3 2022$2,281,000
-35.1%
101,800
-28.2%
0.00%
-50.0%
Q2 2022$3,514,000
-36.1%
141,790
-0.1%
0.00%0.0%
Q1 2022$5,503,000
-33.6%
141,947
+0.3%
0.00%
-33.3%
Q4 2021$8,284,000
-1.3%
141,5900.0%0.00%0.0%
Q3 2021$8,392,000
-32.0%
141,590
-0.4%
0.00%
-40.0%
Q2 2021$12,341,000
+15.9%
142,190
+10.1%
0.01%0.0%
Q1 2021$10,650,000
+18.1%
129,170
+30.2%
0.01%
+25.0%
Q4 2020$9,020,000
+146.9%
99,200
+8.5%
0.00%
+100.0%
Q3 2020$3,653,000
+24.1%
91,400
+6.5%
0.00%0.0%
Q2 2020$2,944,000
+64.3%
85,800
+6.3%
0.00%
+100.0%
Q1 2020$1,792,000
+28.5%
80,700
+13.2%
0.00%0.0%
Q4 2019$1,395,000
+31.1%
71,300
+4.1%
0.00%0.0%
Q3 2019$1,064,000
-23.5%
68,5000.0%0.00%0.0%
Q2 2019$1,391,000
+32.4%
68,500
+14.5%
0.00%0.0%
Q1 2019$1,051,000
+42.0%
59,800
+3.6%
0.00%0.0%
Q4 2018$740,000
+6.6%
57,700
+35.4%
0.00%
Q3 2018$694,000
+121.7%
42,600
+54.3%
0.00%
Q2 2018$313,000
+192.5%
27,600
+150.9%
0.00%
Q1 2018$107,00011,0000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders